Literature DB >> 21078851

Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.

Carl-Fredrik Flach1, Anna Karin Östberg, Anne-Therese Nilsson, Rene De Waal Malefyt, Sukanya Raghavan.   

Abstract

CD4(+) T cells have been shown to be essential for vaccine-induced protection against Helicobacter pylori infection in mice. Less is known about the relative contributions of individual cell subpopulations, such as T(h)1 and T(h)17 cells, and their associated cytokines. The aim of the present study was to find immune correlates to vaccine-induced protection and further study their role in protection against H. pylori infection. Immunized and unimmunized mice were challenged with H. pylori, and immune responses were compared. Vaccine-induced protection was assessed by measuring H. pylori colonization in the stomach. Gastric gene expression of T(h)1- and/or T(h)17-associated cytokines was analyzed by quantitative PCR, and contributions of individual cytokines to protection were evaluated by antibody-mediated in vivo neutralization. By analyzing immunized and unimmunized mice, a significant inverse correlation between the levels of interleukin-12p40 (IL-12p40), tumor necrosis factor alpha (TNF), gamma interferon (IFN-γ), and IL-17 gene expression and the number of H. pylori bacteria in the stomachs of individual animals after challenge could be demonstrated. In a kinetic study, upregulation of TNF, IFN-γ, and IL-17 coincided with vaccine-induced protection at 7 days after H. pylori challenge and was sustained for at least 21 days. In vivo neutralization of these cytokines during the effector phase of the immune response revealed a significant role for IL-17, but not for IFN-γ or TNF, in vaccine-induced protection. In conclusion, although both T(h)1- and T(h)17-associated gene expression in the stomach correlate with vaccine-induced protection against H. pylori infection, our study indicates that mainly T(h)17 effector mechanisms are of critical importance to protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078851      PMCID: PMC3028834          DOI: 10.1128/IAI.00756-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.

Authors:  Ali A Akhiani; Jacques Pappo; Zita Kabok; Karin Schön; Wei Gao; Lennart E Franzén; Nils Lycke
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.

Authors:  S Raghavan; M Hjulström; J Holmgren; A-M Svennerholm
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa.

Authors:  F Luzza; T Parrello; G Monteleone; L Sebkova; M Romano; R Zarrilli; M Imeneo; F Pallone
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach.

Authors:  Sukanya Raghavan; Anna Karin Ostberg; Carl-Fredrik Flach; Annelie Ekman; Margareta Blomquist; Cecil Czerkinsky; Jan Holmgren
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

6.  Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection.

Authors:  Toshiro Yamamoto; Masakazu Kita; Tomoyuki Ohno; Yoichiro Iwakura; Kenji Sekikawa; Jiro Imanishi
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

7.  Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice.

Authors:  Ali A Akhiani; Karin Schön; Nils Lycke
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

Authors:  Christine A Garhart; Frederick P Heinzel; Steven J Czinn; John G Nedrud
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.

Authors:  S Raghavan; A-M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

Authors:  Atsuhiro Ogawa; Akira Andoh; Yoshio Araki; Tadao Bamba; Yoshihide Fujiyama
Journal:  Clin Immunol       Date:  2004-01       Impact factor: 3.969

View more
  21 in total

Review 1.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.

Authors:  John G Nedrud; Nayer Bagheri; Karin Schön; Wei Xin; Hilda Bergroth; Dubravka Grdic Eliasson; Nils Y Lycke
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 3.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Vaccinating against Helicobacter pylori in the developing world.

Authors:  Shamila Zawahir; Steven J Czinn; John G Nedrud; Thomas G Blanchard
Journal:  Gut Microbes       Date:  2013-11-06

5.  Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.

Authors:  Elizabeth S DeLyria; John G Nedrud; Peter B Ernst; Mohammad S Alam; Raymond W Redline; Hua Ding; Steven J Czinn; Jinghua Xu; Thomas G Blanchard
Journal:  Helicobacter       Date:  2011-06       Impact factor: 5.753

6.  A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.

Authors:  Louise Sjökvist Ottsjö; Carl-Fredrik Flach; John Clements; Jan Holmgren; Sukanya Raghavan
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

7.  Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.

Authors:  Amita Joshi; Greg Pancari; Leslie Cope; Edward P Bowman; Daniel Cua; Richard A Proctor; Tessie McNeely
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

8.  Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.

Authors:  Anna K Walduck; Dorit Becher
Journal:  Front Immunol       Date:  2012-10-15       Impact factor: 7.561

9.  Polymorphisms of the DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy.

Authors:  Jing Jiang; Zhifang Jia; Donghui Cao; Mei-Shan Jin; Fei Kong; Jian Suo; Xueyuan Cao
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.

Authors:  Louise Sjökvist Ottsjö; Frida Jeverstam; Linda Yrlid; Alexander U Wenzel; Anna K Walduck; Sukanya Raghavan
Journal:  Immunology       Date:  2016-11-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.